Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingfu Fu

Showing results (161-170 of 268) with videos related to

Pageof 27
Sort By:
Brachytherapy|April 17, 2007
Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusionRodney J Ellis, Hang Zhou, Deborah A Kaminsky, et al.
Frontiers in Immunology|September 8, 2025
A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028Yan Zhang, Ye-Fan Hu, Lingyu Ma, et al.
JTO Clinical and Research Reports|August 22, 2022
Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune DiseaseDemitrios Dedousis, Anastasia N Vassiliou, Shufen Cao, et al.
Leukemia & Lymphoma|July 1, 2024
Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomesKoen van Besien, Hongtao Liu, Seunghee Margevicius, et al.
Blood|February 22, 2003
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell SystemJennifer Jaroscak, Kristin Goltry, Alan Smith, et al.
Biology Direct|January 18, 2012
IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr miceNeil S Greenspan, Myro A Lu, Jacob W Shipley, et al.
Cancer Immunology Research|November 14, 2019
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung CancerMohammadhadi Khorrami, Prateek Prasanna, Amit Gupta, et al.
Ebiomedicine|July 15, 2021
A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancerXiangxue Wang, Kaustav Bera, Cristian Barrera, et al.
British Journal of Haematology|August 7, 2009
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphomaPaul M Barr, Pingfu Fu, Hillard M Lazarus, et al.
Brachytherapy|February 8, 2007
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetideRodney J Ellis, Hang Zhou, Edward Y Kim, et al.
Pageof 27

Showing results (161-170 of 268) with videos related to

Sort By:
Pageof 27
Brachytherapy|April 17, 2007
Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusionRodney J Ellis, Hang Zhou, Deborah A Kaminsky, et al.
Frontiers in Immunology|September 8, 2025
A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028Yan Zhang, Ye-Fan Hu, Lingyu Ma, et al.
JTO Clinical and Research Reports|August 22, 2022
Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune DiseaseDemitrios Dedousis, Anastasia N Vassiliou, Shufen Cao, et al.
Leukemia & Lymphoma|July 1, 2024
Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomesKoen van Besien, Hongtao Liu, Seunghee Margevicius, et al.
Blood|February 22, 2003
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell SystemJennifer Jaroscak, Kristin Goltry, Alan Smith, et al.
Biology Direct|January 18, 2012
IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr miceNeil S Greenspan, Myro A Lu, Jacob W Shipley, et al.
Cancer Immunology Research|November 14, 2019
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung CancerMohammadhadi Khorrami, Prateek Prasanna, Amit Gupta, et al.
Ebiomedicine|July 15, 2021
A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancerXiangxue Wang, Kaustav Bera, Cristian Barrera, et al.
British Journal of Haematology|August 7, 2009
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphomaPaul M Barr, Pingfu Fu, Hillard M Lazarus, et al.
Brachytherapy|February 8, 2007
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetideRodney J Ellis, Hang Zhou, Edward Y Kim, et al.
Pageof 27